SCHEMBL14409788

SCHEMBL14409788

CC(C)(C)C(=O)OCC1OC(OCc2ccccc2)C(O)C(OC(=O)C(C)(C)C)C1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 2/20 0.48
▸ NT5E P21589 1/20 0.41
▸ SLC6A2 P23975 1/20 0.40
▸ SSTR5 P35346 2/20 0.40
▸ SSTR1 P30872 1/20 0.38
▸ SSTR2 P30874 1/20 0.38
▸ SSTR4 P31391 1/20 0.38
▸ SSTR3 P32745 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ FGF1 P05230 2/20 0.37
▸ FGF2 P09038 2/20 0.37
▸ VEGFA P15692 2/20 0.37
▸ HPSE Q9Y251 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TACR2 P21452 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ PRKCA P17252 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629592 1.00 LGALS8 (0.48) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL14075622 1.00 LGALS8 (0.48) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL2629582 0.91 LGALS8 (0.42) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL472852 0.91 LGALS8 (0.42) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL14075626 0.91 LGALS8 (0.42) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL2629589 0.87 LGALS8 (0.43) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL472845 0.87 LGALS8 (0.43) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL14075623 0.87 LGALS8 (0.43) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL10077913 0.87 LGALS8 (0.39) LGALS8NT5ESLC6A2SSTR5SSTR1
SCHEMBL14409790 0.86 NT5E (0.51) NT5ESSTR5SSTR1SSTR2SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637578-B2 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins ISIS INNOVATION LIMITED (GB) 2014-01-28 — — US disclosed
US-20070213506-A1 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins ISIS INNOVATION LIMITED (GB) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213506-A1 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins SCLY, PTMS, TST LGALS8 1044/4885NT5E 3172/4885SLC6A2 2995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback